Peter Sorger, PhD

Otto Krayer Professor of Systems Pharmacology, Harvard Medical School
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
Authors: Authors: Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, Cufer T, Ferrell J, Galas D, Gallahan D, Gatenby R, Goldbeter A, Hace N, Henney A, Hood L, Iyengar R, Jackson V, Kallioniemi O, Klingmüller U, Kolar P, Kolch W, Kyriakopoulou C, Laplace F, Lehrach H, Marcus F, Matrisian L, Nolan G, Pelkmans L, Potti A, Sander C, Seljak M, Singer D, Sorger P, Stunnenberg H, Superti-Furga G, Uhlen M, Vidal M, Weinstein J, Wigle D, Williams M, Wolkenhauer O, Zhivotovsky B, Zinovyev A, Zupan B.
Mol Oncol
View full abstract on Pubmed
Comparative autoregressive moving average analysis of kinetochore microtubule dynamics in yeast.
Authors: Authors: Jaqaman K, Dorn JF, Jelson GS, Tytell JD, Sorger PK, Danuser G.
Biophys J
View full abstract on Pubmed
Molecular organization of the Ndc80 complex, an essential kinetochore component.
Authors: Authors: Wei RR, Sorger PK, Harrison SC.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Electronic detection of DNA by its intrinsic molecular charge.
Authors: Authors: Fritz J, Cooper EB, Gaudet S, Sorger PK, Manalis SR.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
In vitro assays for studying Saccharomyces cerevisiae kinetochore activity.
Authors: Authors: Severin F, Kaplan K, Sorger P, Hyman T.
Methods Cell Biol
View full abstract on Pubmed
Purification and characterization of a heat-shock element binding protein from yeast.
Authors: Authors: Sorger PK, Pelham HR.
EMBO J
View full abstract on Pubmed
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Authors: Authors: Färkkilä A, Gulhan DC, Casado J, Jacobson CA, Nguyen H, Kochupurakkal B, Maliga Z, Yapp C, Chen YA, Schapiro D, Zhou Y, Graham JR, Dezube BJ, Munster P, Santagata S, Garcia E, Rodig S, Lako A, Chowdhury D, Shapiro GI, Matulonis UA, Park PJ, Hautaniemi S, Sorger PK, Swisher EM, D'Andrea AD, Konstantinopoulos PA.
Nat Commun
View full abstract on Pubmed
A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.
Authors: Authors: Palmer AC, Chidley C, Sorger PK.
Elife
View full abstract on Pubmed
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Authors: Authors: Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A.
Cell
View full abstract on Pubmed
Designing Drug-Response Experiments and Quantifying their Results.
Authors: Authors: Hafner M, Niepel M, Subramanian K, Sorger PK.
Curr Protoc Chem Biol
View full abstract on Pubmed